Recall Record

Lugano, N/A, Switzerland

Inpeco S.A. recalls

14 recalls recorded since 2018, most recently on 30 October 2025. 7 are listed as ongoing. Status and classification are as published by the FDA.

Recalls14
Ongoing (FDA)7
Terminated or completed7
Class I (FDA)0

Ongoing Class II Medical devices

Recall started
30 October 2025
Reason
The Aliquoter Module (mALX) may generate secondary sample tubes without labels or with mismatched labels which may result in delayed results or erroneous results, this error occurs if the operators open the printer head of mALX to perform error recoveries or maintenance procedures and do not empty the printer tubes buffer to remove all the secondary sample tubes
Distribution
US Domestic: MI. OUS International: Australia, Finland, France, Germany, Italy, Portugal, Spain, and UK.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0596-2026, Z-0595-2026

Ongoing Class II Medical devices

Recall started
3 September 2025
Reason
The FlexLab X System Sample Integrity Module (SIM) includes function that determines the hemolysis, icterus, and lipemia (HIL) in blood samples. This function has not been evaluated for safety and effectiveness by the FDA, so its use may cause an increase in erroneous results or a delay in patient results.
Distribution
US distribution to CA & NY.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0107-2026, Z-0106-2026

Ongoing Class II Medical devices

Recall started
3 November 2023
Reason
Firmware of the Interface Module with Roche Cobas 8000 and Cobas PRO (CO8 IM) may lead to a delayed sample tube processing.
Distribution
Worldwide - US Nationwide distribution in the state of MA and the countries of AUSTRIA, BELGIUM, DENMARK, ITALY, NORWAY, SPAIN.
Initiated
Voluntary: Firm initiated
Recall number
Z-0560-2024

Ongoing Class II Medical devices

Recall started
10 March 2023
Reason
Firmware versions have the potential to mis-associate sample IDs leading to incorrect results or delayed sodium, potassium, and chloride patient results. Falsely increased or decreased electrolytes can lead to either inappropriate treatment of normal results, or failure to treat abnormal results resulting in abnormal levels. Abnormal potassium levels can result in weakness, polyuria, ileus, psychiatric disturbances, cardiac arrhythmias, respiratory depression, and death. Abnormal sodium levels can result in CNS disturbances and disturbances of water balance. Abnormal chloride levels can lead to acid base disturbances which can lead to respiratory and cardiac compromise. The event may occur only if all the following conditions occurs in few milliseconds timeframe: - The module is releasing a sample tube (Tube A) just placed into the carrier - Another sample tube (Tube B) is erroneously not diverted into the module buffer lane due to a malfunction of the divert gate Only in this specific scenario, the Tube A may be released by the module as Tube B due to a miscommunication between the module firmware and the Automation software without any error message. The Automation System loses the traceability of Tube A. It manages both Tube A (incorrectly identified as Tube B) and the real Tube B according to the test orders not performed yet on Tube B. Inpeco has released a Technical Service Bulletin with the procedure to correctly update the firmware. The firmware upgrade will be performed by Field Service Engineers. A CAPA (Corrective Action Preventive Action) has been opened to deeply investigate the root cause and identify possible process lack in order to avoid reoccurrences.
Distribution
Worldwide distribution - US Nationwide and the countries of ARGENTINA, AUSTRALIA, AUSTRIA, BELGIUM, BRAZIL, CANADA, CHILE, CHINA, COLOMBIA, CZECH REPUBLIC, DENMARK, EAU, EGYPT, FRANCE, GERMANY, GREECE, HUNGARY, INDIA, IRELAND, ISRAEL, ITALY, JAPAN, KENYA, MALAYSIA, MEXICO, MYANMAR, NETHERLANDS, NO
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1560-2023, Z-1559-2023, Z-1562-2023, Z-1561-2023, Z-1563-2023

Ongoing Class II Medical devices

Recall started
10 September 2021
Reason
The Firmware (FW) of the Automation System Interface Module to ADVIA Centaur XP/XPT may lead to an incorrect association of test results to sample ID. Improper management of the sample may bring an incorrect patient result.
Distribution
Domestic distribution nationwide . Foreign distribution worldwide.
Initiated
Voluntary: Firm initiated
Recall number
Z-0087-2022

Terminated Class II Medical devices

Recall started
7 August 2020
Terminated
2 December 2021
Reason
Firmware of the Sysmex XN-9000/XN-9100 Interface Module (IM) and of the Track to Rack Module has the potential to mis-associate sample IDs leading to incorrect results or delayed results
Distribution
Worldwide distribution - US Nationwide distribution including in the states of AK, FL, IA, LA, MA, MS, MT, NC, OH, TX, VA and the countries of AUSTRALIA, AUSTRIA, BELGIUM, DENMARK, FRANCE, GERMANY, ITALY, JAPAN, NETHERLANDS. NORWAY SAUDI ARABIA SOUTH KOREA SWEDEN UNITED ARAB EMIRATES
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2974-2020, Z-2975-2020, Z-2973-2020

Terminated Class II Medical devices

Recall started
14 July 2020
Terminated
28 December 2023
Reason
When a Clot Detection Error is generated during the sample aspiration from the Primary Sample Tube the aspirated volume is dispensed into the first empty Secondary Sample Tube. This Secondary Sample Tube is flagged with error 2132 or 1442 and sent to IOM Priority Output Racks to be manually managed. The current error message associated to error 2132 or 1442 recommends that the operator manages these Secondary Sample Tubes according to Laboratory Practice, but it does not clarify that these Secondary Sample Tubes may be diluted with water from the hydraulic circuit of the Aliquoter Module this may lead to reporting of erroneous results if the diluted sample is used for testing.
Distribution
Global Distribution including: USA and countries of: Algeria, Australia, Azerbaijan, Belgium, Brazil, Canada, Chile, China, Colombia, Croatia, Egypt, Finland, France, Germany, Indonesia, Israel, Italy, Libano, Mexico, Netherlands, Philippines, Portugal, Qatar, Saudi Arabia, Singapore, South Africa,
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0433-2021, Z-0434-2021, Z-0432-2021

Ongoing Class II Medical devices

Recall started
7 April 2020
Reason
The FlexLab Centrifuge Module loading algorithm may lead to unbalanced loads which could damage the centrifuge.
Distribution
Worldwide distribution including the following states: Ohio, New York, Virginia, Pennsylvania, Texas, Delaware, California, Florida, Kentucky, Tennessee, Maryland, Rhode Island, Alabama, Massachusetts, Connecticut, Minnesota, Alabama, Montana, Louisiana, New Jersey, Virginia, New Hampshire, Michigan
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1888-2020, Z-1889-2020, Z-1887-2020

Terminated Class II Medical devices

Recall started
7 April 2020
Terminated
28 July 2022
Reason
When analyzer sample carousel lid remains open or manual process is too long, Module timeout expiry errors could occur causing cross contamination of samples.
Distribution
Worldwide distribution - US Nationwide including in the states of Texas, West Virginia, South Carolina, Delaware, Louisiana, Illinois, Georgia, Florida, New York, Virginia, Arkansas, Wisconsin, California, Minnesota, Missouri, North Carolina, Utah, Michigan, Ohio, Alabama, Oklahoma, Tennessee, Kansa
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2003-2020, Z-2004-2020

Terminated Class II Medical devices

Recall started
7 April 2020
Terminated
6 February 2024
Reason
The identified problem is an erroneous association between the carrier and the sample tube caused by a communication error between the firmware of the Interface Modules and the Automation software. This problem can occur only when one of these Interface Modules is put off-line after a carrier in their secondary lane is physically returned on the main track and then put back on-line when the carrier is used to transport another tube.
Distribution
US Nationwide including in the states of IL, NY.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2141-2020, Z-2140-2020, Z-2142-2020

Ongoing Class II Medical devices

Recall started
7 April 2020
Reason
In certain firmware versions, in case a Clot Detection error (error code E0E0 or 13E0) is generated during the sample aspiration the current error recovery procedure dispenses 2/3 of sample volume back into the Primary Tube. Evidence from the field showed that in case of Clot Detection error, this management may lead to the dilution of the Primary Tube with the distilled water of the hydraulic circuit of the Aliquoter Module.
Distribution
US Nationwide distribution including in the states of IL, NY.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2199-2020, Z-2200-2020, Z-2198-2020

Terminated Class II Medical devices

Recall started
7 April 2020
Terminated
13 June 2024
Reason
The sensors which activate the safety switches may be affected by delayed activation. In 1% of the cases, the response delay can be up to a maximum delay of 2 seconds, instead of 40ms expected by design.
Distribution
The products were distributed to the following US States: IL and NY.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2114-2020, Z-2115-2020

Terminated Class II Medical devices

Recall started
24 August 2018
Terminated
19 March 2020
Reason
The firm has identified customer sites where there are modules on which the safety pacemaker label is missing. The information regarding the label included in the Operations Manual has been updated to specify that: 1) the risk of a pacemaker malfunction applies to anyone with a pacemaker who may work on these modules; and 2) the minimum safety distance has been increased to 200 mm (7.87") from the transport mechanisms. Any person with a pacemaker must not get closer than this distance from the modules axes.
Distribution
Foreign distribution to Netherlands, Italy, Belgium, Austria, France, Spain, and Germany.
Initiated
Voluntary: Firm initiated
Recall number
Z-0361-2019

Terminated Class II Medical devices

Recall started
13 February 2018
Terminated
3 April 2019
Reason
Module may freeze without generating user warning. There is a potential risk in delay of sample processing, leading to delayed delivery of test results to patients.
Distribution
Distributors in 2 states: NY and IL.
Initiated
Voluntary: Firm initiated
Recall number
Z-1798-2018

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.